Improved acylated ghrelin suppression at 2 years in obese patients with type 2 diabetes: effects of bariatric surgery vs standard medical therapy

[1]  K. N. Bojsen-Møller.  Mechanisms of improved glycaemic control after Roux-en-Y gastric bypass. , 2015, Danish medical journal.

[2]  F. Rubino,et al.  Surgical control of obesity and diabetes: The role of intestinal vs. gastric mechanisms in the regulation of body weight and glucose homeostasis , 2014, Obesity.

[3]  J. Kirwan,et al.  The influence of hyperglycemia on the therapeutic effect of exercise on glycemic control in patients with type 2 diabetes mellitus. , 2013, JAMA internal medicine.

[4]  P. Schauer,et al.  Ghrelin suppression is associated with weight loss and insulin action following gastric bypass surgery at 12 months in obese adults with type 2 diabetes , 2013, Diabetes, obesity & metabolism.

[5]  Deepak L. Bhatt,et al.  Metabolic Effects of Bariatric Surgery in Patients With Moderate Obesity and Type 2 Diabetes , 2013, Diabetes Care.

[6]  A. Lacy,et al.  GLP-1 Action and Glucose Tolerance in Subjects With Remission of Type 2 Diabetes After Gastric Bypass Surgery , 2013, Diabetes Care.

[7]  R. Barazzoni,et al.  Gastric bypass does not normalize obesity‐related changes in ghrelin profile and leads to higher acylated ghrelin fraction , 2012, Obesity.

[8]  Haiying Chen,et al.  Association of an intensive lifestyle intervention with remission of type 2 diabetes. , 2012, JAMA.

[9]  M. Kakei,et al.  Exogenous and endogenous ghrelin counteracts GLP‐1 action to stimulate cAMP signaling and insulin secretion in islet β‐cells , 2012, FEBS letters.

[10]  C. Beglinger,et al.  Metabolic and Hormonal Changes After Laparoscopic Roux-en-Y Gastric Bypass and Sleeve Gastrectomy: a Randomized, Prospective Trial , 2012, Obesity Surgery.

[11]  R. Abramof.  Bariatric Surgery versus Intensive Medical Therapy in Obese Patients with Diabetes , 2012 .

[12]  R. Ness-Abramof.  Bariatric Surgery versus Conventional Medical Therapy for Type 2 Diabetes , 2012 .

[13]  H. Buchwald.  Metabolic/bariatric surgery , 2012 .

[14]  W. Cefalu.  Diabetes Care: Change Is Constant , 2011, Diabetes Care.

[15]  B. Braun,et al.  Independent and Combined Effects of Exercise Training and Metformin on Insulin Sensitivity in Individuals With Prediabetes , 2011, Diabetes Care.

[16]  Chih‐Yen Chen,et al.  Changes in postprandial gut hormones after metabolic surgery: a comparison of gastric bypass and sleeve gastrectomy. , 2011, Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery.

[17]  J. Holst,et al.  Changes in glucose homeostasis after Roux-en-Y gastric bypass surgery for obesity at day three, two months, and one year after surgery: role of gut peptides. , 2011, The Journal of clinical endocrinology and metabolism.

[18]  M. Blatnik,et al.  A practical guide for the stabilization of acylghrelin in human blood collections , 2011, Clinical endocrinology.

[19]  B. Fernhall,et al.  Exercise and type 2 diabetes: American College of Sports Medicine and the American Diabetes Association: joint position statement. Exercise and type 2 diabetes. , 2010, Medicine and science in sports and exercise.

[20]  A. Nicolucci,et al.  Effect of an intensive exercise intervention strategy on modifiable cardiovascular risk factors in subjects with type 2 diabetes mellitus: a randomized controlled trial: the Italian Diabetes and Exercise Study (IDES). , 2010, Archives of internal medicine.

[21]  M. Tschöp,et al.  Ghrelin Suppresses Glucose-Stimulated Insulin Secretion and Deteriorates Glucose Tolerance in Healthy Humans , 2010, Diabetes.

[22]  Deepak L. Bhatt,et al.  Bariatric surgery vs. advanced practice medical management in the treatment of type 2 diabetes mellitus: rationale and design of the Surgical Therapy And Medications Potentially Eradicate Diabetes Efficiently trial (STAMPEDE) , 2010, Diabetes, obesity & metabolism.

[23]  P. Schauer,et al.  Acute effects of gastric bypass versus gastric restrictive surgery on β-cell function and insulinotropic hormones in severely obese patients with type 2 diabetes , 2010, International Journal of Obesity.

[24]  B. Ludvik,et al.  Sleeve Gastrectomy as Sole and Definitive Bariatric Procedure: 5-Year Results for Weight Loss and Ghrelin , 2010, Obesity surgery.

[25]  B. Braun,et al.  Physical Activity and Hormonal Regulation of Appetite: Sex Differences and Weight Control , 2010, Exercise and sport sciences reviews.

[26]  B.-L. Yu,et al.  Cholesterol imbalance in adipocytes: a possible mechanism of adipocytes dysfunction in obesity , 2009, Obesity reviews : an official journal of the International Association for the Study of Obesity.

[27]  H. Buchwald,et al.  Metabolic/Bariatric Surgery Worldwide 2008 , 2009, Obesity surgery.

[28]  D. Cummings,et al.  Minireview: Hormonal and metabolic mechanisms of diabetes remission after gastrointestinal surgery. , 2009, Endocrinology.

[29]  J. Zigman,et al.  Ghrelin induces abdominal obesity via GHS-R-dependent lipid retention. , 2009, Molecular endocrinology.

[30]  L. Gormsen,et al.  Visceral fat mass is a strong predictor of circulating ghrelin levels in premenopausal women. , 2009, European journal of endocrinology.

[31]  J. Holst,et al.  Circadian rhythms of GIP and GLP1 in glucose-tolerant and in type 2 diabetic patients after biliopancreatic diversion , 2009, Diabetologia.

[32]  T. Alexandrides,et al.  Weight Loss, Appetite Suppression, and Changes in Fasting and Postprandial Ghrelin and Peptide-YY Levels After Roux-en-Y Gastric Bypass and Sleeve Gastrectomy: A Prospective, Double Blind Study , 2008, Annals of surgery.

[33]  M. Suter,et al.  Effects of Gastric Bypass and Gastric Banding on Glucose Kinetics and Gut Hormone Release , 2008, Obesity.

[34]  J. Holst,et al.  Exaggerated glucagon-like peptide-1 and blunted glucose-dependent insulinotropic peptide secretion are associated with Roux-en-Y gastric bypass but not adjustable gastric banding. , 2007, Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery.

[35]  J. Holst,et al.  Glucagon-like peptide 1 (GLP-1) suppresses ghrelin levels in humans via increased insulin secretion , 2007, Regulatory Peptides.

[36]  L. Lind,et al.  Meal suppression of circulating ghrelin is normalized in obese individuals following gastric bypass surgery , 2007, International Journal of Obesity.

[37]  S. Kahn,et al.  Mechanisms linking obesity to insulin resistance and type 2 diabetes , 2006, Nature.

[38]  P. Chelikani,et al.  Ghrelin Attenuates the Inhibitory Effects of Glucagon-Like Peptide-1 and Peptide YY(3-36) on Food Intake and Gastric Emptying in Rats , 2006, Diabetes.

[39]  P. Pfluger,et al.  Ghrelin action in the brain controls adipocyte metabolism. , 2006, The Journal of clinical investigation.

[40]  H. Yoshimatsu,et al.  Ghrelin regulates adiposity in white adipose tissue and UCP1 mRNA expression in brown adipose tissue in mice , 2005, Regulatory Peptides.

[41]  M. Bessler,et al.  Effects of Roux-en-Y gastric bypass surgery on fasting and postprandial concentrations of plasma ghrelin, peptide YY, and insulin. , 2005, The Journal of clinical endocrinology and metabolism.

[42]  D. Cummings,et al.  Gastric bypass for obesity: mechanisms of weight loss and diabetes resolution. , 2004, The Journal of clinical endocrinology and metabolism.

[43]  C. Gutiérrez,et al.  Resistin, adiponectin, ghrelin, leptin, and proinflammatory cytokines: relationships in obesity. , 2004, Obesity research.

[44]  E. Dellinger,et al.  Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery. , 2002, The New England journal of medicine.

[45]  K. Hosoda,et al.  Stomach is a major source of circulating ghrelin, and feeding state determines plasma ghrelin-like immunoreactivity levels in humans. , 2001, The Journal of clinical endocrinology and metabolism.